The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOxford Nano Regulatory News (ONT)

Share Price Information for Oxford Nano (ONT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 110.10
Bid: 110.20
Ask: 111.40
Change: 0.00 (0.00%)
Spread: 1.20 (1.089%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 110.10
ONT Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Result of AGM

12 Jun 2023 15:30

RNS Number : 4413C
Oxford Nanopore Technologies plc
12 June 2023
 

12 June 2023

Oxford Nanopore Technologies plc

(the "Company")

Results of Annual General Meeting

 

The Annual General Meeting of the Company was held earlier today. All resolutions, as set out in the Company's Notice of Annual General Meeting dated 26 April 2023, were passed by the appropriate majority on a poll. Details of the poll results are set out below.

 

Oxford Nanopore Technologies plc Annual General Meeting Poll Results

 

 

No.

RESOLUTION

VOTESFOR

%

VOTESAGAINST

%

VOTESTOTAL

% of ISC VOTED

VOTESWITHHELD

1.

To receive the Directors' Report, the Audited Statement of Accounts and Auditor's Report of the Company for the financial year ended 31 December 2022

 

598,453,596

100.00%

1,033

0.00%

598,454,629

72.28

280,755

2.

To approve the Directors' Remuneration Report for the year ended 31 December 2022

592,811,165

99.56%

2,623,223

0.44%

595,434,388

71.91

3,300,996

3.

To elect Duncan Tatton-Brown as a director of the Company

591,248,160

98.77%

7,377,936

1.23%

598,626,096

72.30

109,288

4.

To re-elect Wendy Becker as a director of the Company.

586,212,557

97.91%

12,515,759

2.09%

598,728,316

72.31

7,068

5.

To re-elect Clive Brown as a director of the Company

596,970,020

99.78%

1,340,598

0.22%

598,310,618

72.26

424,766

6.

To re-elect Timothy Cowper as a director of the Company

596,826,363

99.75%

1,486,049

0.25%

598,312,412

72.26

422,972

7.

To re-elect Sarah Gordon Wild as a director of the Company

584,609,837

97.90%

12,518,479

2.10%

597,128,316

72.12

1,607,068

8.

To re-elect Dr Guy Harmelin as a director of the Company

572,817,551

95.67%

25,910,765

4.33%

598,728,316

72.31

7,068

9.

To re-elect Adrian Hennah as a director of the Company

566,783,715

95.43%

27,112,846

4.57%

593,896,561

71.73

4,838,823

10. 

To re-elect John O'Higgins as a director of the Company

572,016,953

95.54%

26,709,363

4.46%

598,726,316

72.31

9,068

11. 

To re-elect Dr Gurdial (Gordon) Sanghera as a director of the Company

549,393,123

92.01%

47,684,889

7.99%

597,078,012

72.11

1,657,372

12. 

To re-elect Dr James (Spike) Willcocks as a director of the Company.

597,042,698

99.79%

1,271,166

0.21%

598,313,864

72.26

421,520

13. 

To appoint Deloitte LLP as auditors of the Company

598,703,672

100.00%

24,797

0.00%

598,728,469

72.31

6,915

14. 

To authorise the Audit & Risk Committee to determine the remuneration of the auditors

598,667,218

99.99%

63,251

0.01%

598,730,469

72.31

4,915

15. 

To authorise the Directors to allot shares

591,166,690

98.77%

7,380,042

1.23%

598,546,732

72.29

8,652

16. 

To disapply pre-emption rights*

598,626,103

99.99%

71,647

0.01%

598,697,750

72.31

37,634

17. 

To further disapply pre-emption rights*

595,205,512

99.42%

3,492,238

0.58%

598,697,750

72.31

37,634

18. 

To authorise the Company to make market purchases*

598,612,295

99.99%

78,359

0.01%

598,690,654

72.31

44,730

19. 

To authorise the Company to hold any general meeting (other than an Annual General Meeting) on not less than 14 clear days' notice*

595,535,479

99.47%

3,186,083

0.53%

598,721,562

72.31

13,822

20. 

To authorise UK political expenditure not exceeding £100,000

589,972,140

98.54%

8,716,231

1.46%

598,688,371

72.31

47,013

 

*Special Resolution

 

 

NOTES:

 

1. Votes "For" and "Against" are expressed as a percentage of votes received.

 

2. The total number of ordinary shares in issue and eligible to be voted on at the AGM was 827,997,259.

 

3. A "Vote withheld" is not a vote in law and is not counted in the calculation of the percentage of shares voted "For" or "Against" any resolution nor in the calculation of the proportion of "Total issued share capital voted" for any resolution.

 

In accordance with Listing Rule 9.6.2, a copy of the resolutions will shortly be submitted to the National Storage Mechanism and will be available for inspection at: https://data.fca.org.uk/#/nsm/nationalstoragemechanism.

 

A copy of the poll results for the AGM will also be available shortly on the Company's website at https://nanoporetech.com/about-us/investors/shareholder-information.

 

 

-ENDS-

Enquiries:

Hannah Coote, Company Secretary

cosec@nanoporetech.com 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RAGSFFFLEEDSESM
Date   Source Headline
1st May 20245:00 pmRNSIssue of Equity and Total Voting Rights
1st May 20247:00 amRNSDirector/PDMR Shareholding
30th Apr 20247:00 amRNSPublication of Annual Report and Notice of AGM
12th Apr 20241:00 pmRNSStudy unlocks insights into disease and longevity
12th Apr 202412:00 pmRNSLTIP and DBP; Director/PDMR Notification
11th Apr 20244:00 pmRNSShare Incentive Plan - Director/PDMR Shareholding
8th Apr 20244:00 pmRNSBlock Listing Interim Review
2nd Apr 20242:00 pmRNSIssue of Equity and Total Voting Rights
28th Mar 20245:55 pmRNSHolding(s) in Company
12th Mar 20244:00 pmRNSShare Incentive Plan - Director/PDMR Shareholding
12th Mar 20247:00 amRNSOxford Nanopore to Present at Barclays Conference
8th Mar 202412:00 pmRNSDirector/PDMR Shareholding
7th Mar 20247:00 amRNSDirector/PDMR Shareholding
6th Mar 20247:00 amRNSFY23 Preliminary Results
1st Mar 20242:00 pmRNSIssue of Equity and Total Voting Rights
29th Feb 20246:00 pmRNSDirectorate Change
13th Feb 20244:00 pmRNSShare Incentive Plan - Director/PDMR Shareholding
2nd Feb 20244:30 pmRNSHolding(s) in Company
1st Feb 202412:00 pmRNSIssue of Equity and Total Voting Rights
22nd Jan 20247:00 amRNSExpansion of leadership team
11th Jan 20245:30 pmRNSShare Incentive Plan - Director/PDMR Shareholding
11th Jan 20245:30 pmRNSEmployee Stock Purchase Plan - PDMR Notification
9th Jan 20247:00 amRNSFY23 trading update
3rd Jan 20247:00 amRNSPresentation at 42nd Annual J.P. Morgan Conference
19th Dec 20232:00 pmRNSAppointment of Two Non-Executive Directors
12th Dec 20235:00 pmRNSShare Incentive Plan - Director/PDMR Shareholding
7th Dec 20234:30 pmRNSNanopore Community Meeting Technology Update
1st Dec 20235:00 pmRNSIssue of Equity and Total Voting Rights
30th Nov 20237:00 amRNSNational Australian rare disease programme
13th Nov 20235:00 pmRNSShare Incentive Plan - Director/PDMR Shareholding
13th Nov 202312:00 pmRNSParticipation in upcoming investor conferences
7th Nov 20238:30 amRNSAdmission to Trading on the London Stock Exchange
6th Nov 20237:00 amRNSIssue of Equity
1st Nov 20234:00 pmRNSIssue of Equity and Total Voting Rights
31st Oct 20237:00 amRNSApple showcases Oxford Nanopore in M3 launch
26th Oct 20236:10 pmRNSHolding(s) in Company
24th Oct 202312:30 pmRNSHolding(s) in Company
23rd Oct 20238:30 amRNSIssue of Equity and Total Voting Rights
23rd Oct 20238:30 amRNSAdmission to Trading on the London Stock Exchange
19th Oct 20237:00 amRNSCapital Markets Day - ONT expands into clinical
19th Oct 20237:00 amRNSbioMérieux makes investment in Oxford Nanopore
19th Oct 20237:00 amRNSMayo Clinic and Oxford Nanopore collaboration
11th Oct 20233:30 pmRNSShare Incentive Plan - Director/PDMR Shareholding
6th Oct 20233:00 pmRNSBlock Listing Interim Review
2nd Oct 20234:00 pmRNSIssue of Equity and Total Voting Rights
27th Sep 20235:00 pmRNSDirector Declaration
12th Sep 20233:00 pmRNSShare Incentive Plan - Director/PDMR Shareholding
12th Sep 20237:00 amRNSPresentation at the Morgan Stanley Conference
6th Sep 20237:00 amRNSInterim results for the 6 months ended 30 June 23
1st Sep 20233:00 pmRNSIssue of Equity and Total Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.